VeriMomoligopeptide-55 hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
Related ingredients
Frequently asked questions
- oligopeptide-55 hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
- oligopeptide-55 emzirirken güvenli mi?
- No data indicating lactation transfer or effects on nursing infants. No classifications or published evidence of systemic reproductive/endocrine activity. Given expected low dermal absorption for oligopeptides, systemic exposure to nursing parent is expected to be negligible for typical topical cosmetic use.
- oligopeptide-55 bebek cildi için güvenli mi?
- No evidence of hazard or mechanism specific to infants. Dermal absorption of intact oligopeptides is generally low, but infant skin has immature barrier and higher surface-area-to-weight; therefore exposure (e) is increased by one category relative to adults (adult e=0 → baby e=1) despite no hazard data. No infant-specific studies were found.
- VeriMom oligopeptide-55 nasıl puanlıyor?
- VeriMom oligopeptide-55'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte oligopeptide-55 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.